|
Kidney Function |
17103 |
Metabolomics and Methylation of APOL1 carriers with increase risk of kidney disease [nid:17005] |
Maggie Stanislawski |
|
Kidney Function |
10757 |
NOVEL METABOLOMIC PATHWAYS FOR HYPERURICEMIA AND GOUT |
Laura Raffield |
|
Kidney Function |
1185 |
Structural variants at the alpha-globin locus: main effects and effect modification on blood cell and renal traits in the Jackson Heart Study |
Alex Reiner |
|
Kidney Function |
385 |
The impact of natural selection on human genetic variation |
Ryan Hernandez |
|
Kidney Function |
1996 |
TonEBP mediates hyperglycemia mediated inflammatory, renal and vascular injury |
Afshin Parsa |
|
Kidney Function |
15809 |
Use of Partial Polygenic Risk Scores for Lab Assays to Improve GFR Estimating Equation in MESA |
Laura Zhou |
|
Kidney Function |
257 |
WGS of CVD risk factors and biomarkers in FHS |
Caroline Fox |
|
Kidney Function |
1257 |
Whole genome sequence analysis for serum urate concentrations and gout in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program |
Anna Kottgen |
|
Kidney Function |
5688 |
Whole Genome Sequence Analysis of Risk Factors for and Sequelae from Hypertension in the Genetic Epidemiology of Arteriopathy (GENOA) cohort in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program |
Patricia Peyser |
|
Kidney Function |
2008 |
Whole Genome Sequence Analysis of Risk Factors for and Sequelae from Hypertension in the Genetic Epidemiology of Arteriopathy (GENOA) cohort in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program |
Patricia Peyser |
